The race to create an oral GLP-1 obesity drug: 4 things to know

The push to develop the first oral GLP-1 receptor drug for obesity is heating up, as three phase 3 drugs race to become the first approved oral treatment for obesity, Global Data reported Dec. 2. 

Read the full post on Becker's Hospital Review | Healthcare News & Analysis